192 related articles for article (PubMed ID: 28404817)
1. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
[TBL] [Abstract][Full Text] [Related]
2. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.
Shintani K; Matsumine A; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Hoki Y; Uchida A
Virchows Arch; 2006 Dec; 449(6):673-81. PubMed ID: 17103226
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
5. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
[TBL] [Abstract][Full Text] [Related]
6. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
10. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Ozcelik M; Seker M; Eraslan E; Koca S; Yazilitas D; Ercelep O; Ozaslan E; Kaya S; Hacibekiroglu I; Menekse S; Aksoy A; Taskoylu BY; Varol U; Arpaci E; Ciltas A; Oksuzoglu B; Zengin N; Gumus M; Aliustaoglu M
Tumour Biol; 2016 Apr; 37(4):5231-7. PubMed ID: 26553363
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
Asano N; Yoshida A; Ogura K; Kobayashi E; Susa M; Morioka H; Iwata S; Ishii T; Hiruma T; Chuman H; Kawai A
Ann Surg Oncol; 2015 Aug; 22(8):2624-32. PubMed ID: 25663591
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
15. Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas.
Khoja H; Griffin A; Dickson B; Wunder J; Ferguson P; Howarth D; Kandel R
Arch Pathol Lab Med; 2013 Dec; 137(12):1774-9. PubMed ID: 24283858
[TBL] [Abstract][Full Text] [Related]
16. Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.
Toulmonde M; Le Cesne A; Mendiboure J; Blay JY; Piperno-Neumann S; Chevreau C; Delcambre C; Penel N; Terrier P; Ranchère-Vince D; Lae M; Le Guellec S; Michels JJ; Robin YM; Bellera C; Italiano A
Cancer; 2014 Oct; 120(19):3003-6. PubMed ID: 24942887
[TBL] [Abstract][Full Text] [Related]
17. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
18. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
19. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
20. Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.
Piano MA; Brunello A; Cappellesso R; Del Bianco P; Mattiolo A; Fritegotto C; Montini B; Zamuner C; Del Fiore P; Rastrelli M; Sommariva A; De Salvo GL; Montesco MC; Rossi CR; Zagonel V; Calabrò ML
Clin Cancer Res; 2020 Jun; 26(12):2921-2931. PubMed ID: 32127392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
